Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
Status:
Not yet recruiting
Trial end date:
2027-02-28
Target enrollment:
Participant gender:
Summary
Two-hundred and eighty individuals with schizophrenia who have a recent history of violent
acts will be randomized in this 2-arm, parallel-group, 24-week, open-label, 7-site clinical
trial to examine the effects of treatment with clozapine vs antipsychotic treatment as usual
(TAU) for reducing the risk of violent acts in real-world settings